Depression: The Case for Ketamine
Ketamine. For some people with treatment-resistant depression, this experimental therapy proved to be more than just life-changing—it was lifesaving. But how did a drug once used as a battlefield anesthetic evolve into esketamine, a treatment for major depressive illnesses? In this episode, we’ll talk with Dr. Carlos Zarate Jr., who helped lay the groundwork for esketamine for treatment-resistant depression. We’ll learn the history behind the development of esketamine, how it can help with depression, and what the future holds for this innovative line of clinical research.
Related Posts
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults
The proposed concept encourages effectiveness research that will adapt, optimize...
Emergency Department Intervention Reduces Adult Suicide Risk
Evidence-based practices for suicide prevention effectively reduced suicidal...
Combined, High Maternal Stress and Prenatal COVID-19 Infection May Affect Attention Span in Infants
Prenatal COVID-19 infection increased the risk for impaired attention and delayed...
NIMH Intramural Research Program Training Opportunities
Attend a virtual session to learn about training opportunities in the NIMH...